Recently, Byler et al. concluded the potential activity of Boswellia resin in Alzheimer’s disease using a docking study, through its effect on acetylcholinesterase (AChE) (Byler and Setzer 2018). The gene discussed is ACHE; the disease is Alzheimer disease.